Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.110
+0.100 (2.49%)
At close: Mar 9, 2026, 4:00 PM EDT
4.150
+0.040 (0.97%)
After-hours: Mar 9, 2026, 6:02 PM EDT
Prime Medicine Revenue
In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth. Prime Medicine had revenue of $838.00K in the quarter ending December 31, 2025, a decrease of -61.61%.
Revenue (ttm)
$4.63M
Revenue Growth
+55.28%
P/S Ratio
155.59
Revenue / Employee
$21,645
Employees
214
Market Cap
727.80M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MiMedx Group | 418.63M |
| Gyre Therapeutics | 107.27M |
| Theravance Biopharma | 80.33M |
| Lexicon Pharmaceuticals | 49.80M |
| ProKidney | 744.00K |
PRME News
- 3 days ago - Prime Medicine, Inc. (PRME) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 6 days ago - Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 12 days ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond - Seeking Alpha
- 3 months ago - Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease - GlobeNewsWire
- 3 months ago - Prime Medicine to Present at 8th Annual Evercore Healthcare Conference - GlobeNewsWire